Market Access News | pharmaphorum

News

Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad.

News

MSD has opened the doors of a $1bn facility at its site in Durham, North Carolina, that will be used to produce its HPV vaccine Gardasil.

News

The shake-up of NHS England looks like it could go up a notch, as reports suggest thousands of job cuts that could halve its headcount are planned.

News

AstraZeneca and Ionis add an EU green light to earlier approvals in the US and UK for ATTR polyneuropathy drug Wainzua, a potential blockbuster.

News

Neurotech Pharma's cell therapy Encelto has become the first FDA-approved therapy for idiopathic macular telangiectasia type 2.

News

President Trump's pick to lead the FDA, Martin Makary, was challenged on vaccines, the abortion pill, and FDA staffing decisions at a Senate hearing.